Avanos Medical, Inc. (AVNS): Price and Financial Metrics

Avanos Medical, Inc. (AVNS)

Today's Latest Price: $38.07 USD

0.26 (-0.68%)

Updated Oct 23 7:00pm

Add AVNS to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 142 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

AVNS Stock Summary

  • With a one year PEG ratio of 399.35, Avanos Medical Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 91.45% of US stocks.
  • AVNS's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of merely 20.61% of US stocks.
  • In terms of volatility of its share price, AVNS is more volatile than only 10.65% of stocks we're observing.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Avanos Medical Inc are MSON, NVT, LIQT, ICLK, and NTWK.
  • Visit AVNS's SEC page to see the company's official filings. To visit the company's web site, go to avanos.com.

AVNS Stock Price Chart Interactive Chart >

Price chart for AVNS

AVNS Price/Volume Stats

Current price $38.07 52-week high $48.07
Prev. close $38.33 52-week low $19.46
Day low $37.67 Volume 152,555
Day high $38.87 Avg. volume 341,539
50-day MA $34.13 Dividend yield N/A
200-day MA $30.74 Market Cap 1.82B

Avanos Medical, Inc. (AVNS) Company Bio

Avanos Medical, Inc. (formerly Halyard Health) is focused on preventing infection, eliminating pain and speeding recovery for healthcare providers and their patients. The company was founded in 2014 and is based in Alpharetta, Georgia.

AVNS Latest News Stream

Event/Time News Detail
Loading, please wait...

AVNS Latest Social Stream

Loading social stream, please wait...

View Full AVNS Social Stream

Latest AVNS News From Around the Web

Below are the latest news stories about Avanos Medical Inc that investors may wish to consider to help them evaluate AVNS as an investment opportunity.

Here's Why You Should Retain Avanos Medical Stock for Now

Investor confidence is high on Avanos Medical (AVNS), thanks to solid prospects.

Yahoo | July 8, 2020

MiMedx Announces Concurrent $150 Million Private Equity and Debt Financings

MiMedx Group, Inc. (OTC PINK: MDXG) (“MiMedx” or “the Company”), an industry leader in advanced wound care and an emerging therapeutic biologics company, today announced the closing of concurrent $150 million private equity and debt financings, consisting of an equity financing pursuant to a Securities Purchase Agreement with an entity controlled by EW Healthcare Partners and certain funds managed by Hayfin Capital Management LLP (“Hayfin”), and a debt financing pursuant to a Loan Agreement with Hayfin. As part of the transaction, EW Healthcare Partners has designated Martin P. Sutter and William A. Hawkins III to serve on the Company’s board as preferred directors.

Yahoo | July 2, 2020

Hedge Funds Are Piling Into Avanos Medical (AVNS)

The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter. Even though it isn't the intention, these filings to a certain extent level the playing field for ordinary investors. The latest round of 13F […]

Yahoo | June 28, 2020

Avanos Medical (AVNS) Up 0.1% Since Last Earnings Report: Can It Continue?

Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Investment Research | June 5, 2020

Edited Transcript of AVNS earnings conference call or presentation 6-May-20 1:00pm GMT

Q1 2020 Avanos Medical Inc Earnings Call

Yahoo | June 3, 2020

Read More 'AVNS' Stories Here

AVNS Price Returns

1-mo 14.60%
3-mo 19.87%
6-mo 21.05%
1-year -10.09%
3-year -13.60%
5-year 35.48%
YTD 12.97%
2019 -24.76%
2018 -3.01%
2017 24.88%
2016 10.69%
2015 -26.52%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.8216 seconds.